Evidence map›Paper›PMID 38340165›Full record

Trial reportUrolithiasis2024

RIRS with FV-UAS vs. MPCNL for 2-3-cm upper urinary tract stones: a prospective study.

Du-Jian Wang, Ping Liang, Tian-Xiao Yang, Yi-Qing Liu, Qing-Lai Tang, Xing-Zhu Zhou, Rong-Zhen Tao

Abstract readRandomized Controlled TrialLetter
PubMed Publisher
In one paragraph

Trial report in Urolithiasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Du-Jian Wang *The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Ping Liang *Nanjing Second Hospital, Nanjing, China.
Tian-Xiao Yang *The Affiliated Hospital of Chifeng University, Inner Mongolia, Chifeng, China.
Yi-Qing Liu *Guanyun People's Hospital, Lian Yungang, China.
Qing-Lai TangThe Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Xing-Zhu ZhouThe Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Rong-Zhen TaoThe Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. 18915973028@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To observe the efficacy and safety of retrograde intrarenal surgery (RIRS) combined with flexible vacuum-assisted ureteral access sheath (FV-UAS) and minimally invasive percutaneous nephrolithotomy (MPCNL) in patients with 2-3 cm upper urinary tract stones. A total of 160 patients with 2-3 cm upper urinary tract stones were prospectively randomized into 2 groups-80 in the FV-UAS group and 80 cases as control in the MPCNL group. The stone-free rates (SFRs) at different times (postoperative 1st day and 4th week) were considered as the primary outcome of the study. The secondary end points were operative time, hemoglobin decrease, postoperative hospital stay, and operation-related complications. There was no obvious difference between the two groups in patient's demographics and preoperative clinical characteristics (all P > 0.05). Postoperative data showed that mean decrease in hemoglobin level was less in FV-UAS group than that in MPCNL group (5.3 vs. 10.8 g/L, P < 0.001). Postoperative hospital stay in FV-UAS group was more shorten than that in MPCNL group (2.7 vs. 4.9 days, P < 0.001). There was no statistical significance between the two groups in SFRs during postoperative 1st day and 4th week (both P > 0.05). However, in terms of the rates of bleeding and pain, MPCNL group were both significantly higher than FV-UAS group (6.2 vs. 0.0%, P = 0.023; 16.2 vs. 2.5%, P = 0.003; respectively). Our study showed that RIRS with FV-UAS, a new partnership to treat 2-3 cm upper urinary tract stones, was satisfying as it achieved a high SFR rate and a low rate of complications. This method was safe and reproducible in clinical practice.

Indexed as

Kidney CalculiUrinary CalculiHemoglobinsHumansProspective StudiesTreatment OutcomeHemoglobinsFlexible vacuum-assisted ureteral access sheathMinimally invasive percutaneous nephrolithotomyRetrograde intrarenal surgeryStone-free ratesUpper urinary tract stones

Identifiers

PMID38340165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.